Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
$1.28B |
| 2 |
Apple
AAPL
|
$1.23B |
| 3 |
Broadcom
AVGO
|
$682M |
| 4 |
Amazon
AMZN
|
$629M |
| 5 |
Palo Alto Networks
PANW
|
$595M |
Top Sells
| 1 |
Procter & Gamble
PG
|
$247M |
| 2 |
Cadence Design Systems
CDNS
|
$160M |
| 3 |
O'Reilly Automotive
ORLY
|
$155M |
| 4 |
Synopsys
SNPS
|
$145M |
| 5 |
Chipotle Mexican Grill
CMG
|
$135M |
Sector Composition
| 1 | Technology | 28.26% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Deere & Co
DE
$130B
| $1.98B | 0.23% | 4,890,455 +83,329 | +2% | +$33.7M |
|
77
Goldman Sachs
GS
$225B
| $1.96B | 0.23% | 6,081,153 +10,971 | +0.2% | +$3.53M |
|
78
Vertex Pharmaceuticals
VRTX
$101B
| $1.95B | 0.23% | 5,544,861 +135,604 | +3% | +$47.6M |
|
79
American Tower
AMT
$94.6B
| $1.93B | 0.23% | 9,985,648 +251,834 | +3% | +$48.7M |
|
80
Elevance Health
ELV
$71.2B
| $1.92B | 0.23% | 4,341,458 +63,121 | +1% | +$28M |
|
81
American Express
AXP
$230B
| $1.88B | 0.22% | 10,817,376 +214,837 | +2% | +$37.3M |
|
82
Blackrock
BLK
$174B
| $1.88B | 0.22% | 2,723,629 +59,298 | +2% | +$40.9M |
|
83
Mondelez International
MDLZ
$79.1B
| $1.88B | 0.22% | 25,791,257 +563,052 | +2% | +$40.9M |
|
84
Stryker
SYK
$149B
| $1.87B | 0.22% | 6,135,106 +181,068 | +3% | +$55.1M |
|
85
Analog Devices
ADI
$124B
| $1.86B | 0.22% | 9,594,363 +200,496 | +2% | +$39M |
|
86
Gilead Sciences
GILD
$139B
| $1.86B | 0.22% | 24,212,636 +447,585 | +2% | +$34.4M |
|
87
Lam Research
LRCX
$126B
| $1.85B | 0.22% | 2,883,265 +340,460 | +13% | +$218M |
|
88
TJX Companies
TJX
$152B
| $1.81B | 0.21% | 21,447,146 +555,639 | +3% | +$47M |
|
89
Marsh & McLennan
MMC
$101B
| $1.81B | 0.21% | 9,633,135 -657,382 | -6% | -$123M |
|
90
Zoetis
ZTS
$69.1B
| $1.72B | 0.2% | 10,031,189 +291,819 | +3% | +$50.1M |
|
91
Altria Group
MO
$112B
| $1.67B | 0.2% | 37,025,033 +1,168,982 | +3% | +$52.8M |
|
92
T-Mobile US
TMUS
$281B
| $1.67B | 0.2% | 12,070,277 +6,550 | +0.1% | +$907K |
|
93
Citigroup
C
$177B
| $1.66B | 0.19% | 36,038,176 +859,170 | +2% | +$39.5M |
|
94
Regeneron Pharmaceuticals
REGN
$61.3B
| $1.64B | 0.19% | 2,281,129 +63,136 | +3% | +$45.3M |
|
95
Equinix
EQIX
$77.2B
| $1.62B | 0.19% | 2,071,979 +67,971 | +3% | +$53.2M |
|
96
CVS Health
CVS
$91.9B
| $1.61B | 0.19% | 23,325,287 +363,384 | +2% | +$25M |
|
97
Chubb
CB
$110B
| $1.53B | 0.18% | 7,982,696 +149,362 | +2% | +$28.7M |
|
98
Charles Schwab
SCHW
$173B
| $1.53B | 0.18% | 27,069,333 +19,165 | +0.1% | +$1.08M |
|
99
Cigna
CI
$80.4B
| $1.51B | 0.18% | 5,410,133 +40,100 | +0.7% | +$11.2M |
|
100
Fiserv
FI
$75.2B
| $1.51B | 0.18% | 11,992,520 -429,356 | -3% | -$54M |
|